They sold RXII share and made $,RXII pps has drop almost to 52wk low, CYTR almost 52wk low. On the 10q they said they have enough cash and liquidable equity to fund their research. they still hold 17% of Rxii. Low flow,and no need to dilute,if one drug can get FDA approval. Thinking about getting in but haven't done enough research. Anyone have good insight infor on this company,and what the drugs are worth if it gets approve. GLTA
Market Data 
Markets 
AI
